Other Transaction Agreement W911QY2190006

Award Date 10/30/20
Potential Completion Date 10/30/21
Potential Value $27M
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
NAICS Category
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
West Warwick, RI 02893, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
America's Blood Centers, doing business as ABC, has been awarded a definitive contract valued at $544.4 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to provide convalescent plasma units through April 16, 2021. ABC will serve as the prime contractor, with performance taking place in Washington, D.C. Funded under the Coronavirus COVID-19 National Interest Action Code, this firm fixed price contract supports HHS ASPR's...
The Defense Health Agency awarded a $1.875 million firm fixed price blanket purchase agreement call contract to Blood Centers of America, Inc. for COVID-19 convalescent plasma. Under this contract, Blood Centers of America will provide convalescent plasma to support the Department of Defense's response to the coronavirus pandemic from its facility in Mosby, Virginia. The one month period of performance from June 1, 2020 to July 2, 2020 indicates this was an urgent action to obtain plasma with...
This federal contract award was made by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Blood Centers of America, Inc. (BCA), a for-profit organization. The $34,961.25 firm fixed price contract was for the provision of COVID-19 convalescent serum to support the medical response to the coronavirus pandemic. No set-aside designation was used. BCA has received over $6 million in prior prime contracts from HHS ASPR and the...
This federal contract award is for the delivery of COVID-19 convalescent serum by Blood Centers of America, Inc. (BCA), a for-profit organization, to the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract has a firm fixed price of $75,000.00 and a completion date of November 24, 2020. No set-aside designation is noted. Additionally, BCA has received over $6 million in prime federal contracts from the...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded an Other Transaction Agreement to Emergent Biosolutions Canada Inc. valued at $34.6 million to support the development of human immune globulin (COVID-HIG) manufactured from human plasma with antibodies to SARS-CoV-2. The contract aims to prevent coronavirus disease (COVID-19) through October 2022. Performance will take place at Emergent Biosolutions Canada Inc.'s facility in Ottawa,...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Astrazeneca Pharmaceuticals LP a $439.2 million Other Transaction Agreement to deliver a "COVID-19" monoclonal antibody therapeutic prototype. Performance will occur in Talleyville, Delaware through August 2022. As part of the larger Joint Project Manager for Medical Countermeasure Systems portfolio addressing chemical and biological threats, this appears to support the development...
<p>This is a federal contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Cone Bioproducts Of Seguin, LLC, a self-certified small disadvantaged business. The contract is for the procurement of defibrinated plasma from vaccinated subjects, with a firm fixed price of $46,219.68 and an ultimate completion date of July 12, 2023. The contract was awarded on May 31, 2023 and does not utilize any set-aside designation.</p>
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $262,265 delivery order to Cepheid, a subsidiary of Danaher Corporation, to support COVID-19 response efforts. The firm fixed price order is being performed under the National Interest Action Code for Coronavirus at Fort Liberty, North Carolina through October 2021. The contract calls for Cepheid to provide products and services in support of the Army's $000 major program for chemical and...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price purchase order to Cone Bioproducts of Seguin, LLC, a self-certified small disadvantaged business, to provide defibrinated plasma from vaccinated subjects. The contract has a potential value of $230,210.55 and a completion date of December 30, 2022. The requirement stems from an urgent need to source and convert plasma from COVID-19-naive individuals who have been...
This contract award to Bloodworks, doing business as Puget Sound Blood Center and Program, provides SARS-CoV-2 viral particle neutralization services for the U.S. government. The $161,000 firm-fixed-price delivery order was issued by the U.S. Army Medical Command (MEDCOM) and does not have a set-aside designation. Bloodworks is an independent, community-based nonprofit organization that specializes in transfusion medicine and blood services. The organization holds several significant...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $26.7 million other transaction agreement to America's Blood Centers 501C(6) Trade Association Division, doing business as ABC, to support the "COVID-19" PROTOTYPE PLASMA COLLECTION CAPABILITY. Under this contract, ABC will provide plasma collection services to the Army through October 2021. The work will be performed in West Warwick, Rhode Island. No set aside designation or subcontractors were identified. This award advances the Army's chemical and biological defense programs by establishing domestic plasma collection capabilities that can potentially help treat COVID-19 patients.

Generated 12/25/23, 5:30 AM